Participants with higher NT-proBNP were more likely to be older and NSTEMI; have diabetes, previous hypertension, previous myocardial infarction, previous stroke, and previous PCI; have higher levels of FPG, HbA1c and hs-CRP; have lower levels of BMI, diastolic blood pressure, LVEF, hemoglobin, triglyceride, and eGFR; and have a higher rate of receiving clopidogrel or ticagrelor, β-Blocker, ACEI/ARB and PCI during hospitalization. This evidence concerns the gene NPPB and myocardial infarction.